ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

New cancer treatments have perplexing side effects – Washington Post

Continue reading

2018-01-02 Michael Zand NEWS

Scientists are genetically engineering immune systems to attack and destroy HIV – Quartz

QuartzScientists are genetically engineering immune systems to attack and destroy HIVQuartzThe experiment involved genetically modifying stem cells to produce immune-system T cells and other blood cells with a specific chimeric antigen receptor (CAR) t… Continue reading

2018-01-02 Michael Zand NEWS

Engineered Stem Cells Show Promise vs HIV (STAT – MedPage Today


Washington Post

New cancer treatments have perplexing side effects
Washington Post
When Diane Legg began seeing black specks in her right eye, she went to an ophthalmologist near her home in Amesbury, Mass. He said she had a torn retina and needed laser surgery. Legg’s oncologist was skeptical. He was worried that Legg had eye …

and more »

Continue reading

2018-01-02 Michael Zand NEWS

Why 2017 Was a Year to Remember for Juno Therapeutics – Motley Fool


Quartz

Engineered Stem Cells Show Promise vs HIV (STAT
MedPage Today
Genetically engineered stem cells that can target HIV and interferes with the virus’ ability to enter the cell may represent a novel treatment for HIV/AIDS, according to a report in STAT. Lab studies and administration of the chimeric antigen receptors …
Scientists are genetically engineering immune systems to attack and destroy HIVQuartz

all 2 news articles »

Continue reading

2018-01-02 Michael Zand NEWS

Dr. Sonpavde on the Potential for Immunotherapy in Penile Cancer – OncLive

Dr. Sonpavde on the Potential for Immunotherapy in Penile CancerOncLiveGuru Sonpavde, MD, director of Bladder Cancer at the Dana-Farber Cancer Institute, discusses the potential for immunotherapy in penile cancer. There is promise for PD-1 checkpoint i… Continue reading

2018-01-02 Michael Zand NEWS

Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer – Science

Why 2017 Was a Year to Remember for Juno Therapeutics
Motley Fool
JCAR017, the new star of Juno’s pipeline, uses the same basic principle as JCAR015; both are chimeric antigen receptor T–cell (CAR-T) therapies that train T–cells to target cancerous cells expressing a protein called CD19, but JCAR017 uses a fixed …

and more »

Continue reading

2018-01-02 Michael Zand NEWS

NIH discovery brings stem cell therapy for eye disease closer to the clinic – National Institutes of Health (press release)

National Institutes of Health (press release)NIH discovery brings stem cell therapy for eye disease closer to the clinicNational Institutes of Health (press release)Scientists at the National Eye Institute (NEI), part of the National Institutes of Heal… Continue reading

2018-01-02 Michael Zand NEWS

Discovery brings stem cell therapy for eye disease closer to the clinic – Medical Xpress

Medical XpressDiscovery brings stem cell therapy for eye disease closer to the clinicMedical XpressRPE cell borders are stained showing tight junction markers. Credit: Ruchi Sharma, Ph.D., NEI. Scientists at the National Eye Institute (NEI), part of th… Continue reading

2018-01-02 Michael Zand NEWS
  • 1
  • …
  • 722
  • 723
  • 724
  • 725
  • 726
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer
Science
Cancer immunotherapy attempts to stimulate the patient’s own immune system against a tumor, but despite its potential, the clinical efficacy of immunotherapy has been extremely limited. In some cases, the patient’s own immune system can counteract …